NCT00211146View on ClinicalTrials.gov

A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

680

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

May 31, 2006

Conditions
AnemiaVenous Thrombosis
Interventions
DRUG

epoetin alfa

Sponsors

Collaborators (1)

Ortho Biotech, Inc.
All Listed Sponsors
collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00211146 - A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) | Biotech Hunter | Biotech Hunter